Biotech

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Landauer Inc (NYSE:LDR) reported that  Gilead Capital Lp has picked up 481,415 of common stock as of 2016-12-19. The acquisition brings the aggregate amount owned by Gilead Capital Lp to a total of 481,415 representing...

Price T Rowe is on a buying spree right now, and has today reported a host of transactions, with a primary focus on the biotech space. Spark Therapeutics was a major benefactor from the spree - here are the details. In a just published Form 13, filed with the US...

Cytori Therapeutics Inc (NASDAQ:CYTX) shares advanced 35.92% to $3.33 on Tuesday after the company announced that it would present an update on their clinical trials during the 104th Annual Meeting of the Japan Society of Aesthetic Surgery in Tokyo, Japan. Cytori Therapeutics Inc (NASDAQ:CYTX) shares retreated 3.90% to $3.20 in after-hours...

SurModics, Inc. (NASDAQ:SRDX) share prices surged 16.20% to $23.10 after the company printed an upbeat earnings report and gained an "Outperform" rating from Barrington Research this week. SurModics, Inc. (NASDAQ:SRDX) is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. It operates in two main segments:...

Concert Pharmaceuticals Inc (NASDAQ:CNCE) shares closed 9.87% higher on Friday to $11.13, still within the lower part of its 52-week range of $9.81 to $25.04. Concert Pharmaceuticals Inc (NASDAQ:CNCE) shares dropped sharply at the start of May even after the company reported its CTP-543 drug for the treatment of alopecia...